[1] |
Valery PC, Laversanne M, Clark PJ, et al. Projections of primary liver cancer to 2030 in 30 countries worldwide[J]. Hepatology, 2018, 67(2): 600-611.
|
[2] |
Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis[J]. Am J Gastroenterol, 2000, 95(1): 204-207.
|
[3] |
Höblinger A, Gerhardt T, Gonzalez-Carmona MA, et al. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma[J]. Eur J Med Res, 2011, 16(9): 391-395.
|
[4] |
Lu Y, Liu L, Wu JC, et al. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2015, 39(6): 718-724.
|
[5] |
Donohoe C, Senge MO, Arnaut LG, et al. Cell death in photodynamic therapy: from oxidative stress to anti-tumor immunity[J]. Biochim Biophys Acta Rev Cancer, 2019, 1872(2): 188308.
|
[6] |
袁耒, 邹志强, 李传海, 等. 早期食管癌的光动力治疗[J/CD]. 中华消化病与影像杂志(电子版), 2022, 12(5): 306-309.
|
[7] |
Dichiara M, Prezzavento O, Marrazzo A, et al. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents[J]. Eur J Med Chem, 2017, 142: 459-485.
|
[8] |
Obaid G, Broekgaarden M, Bulin AL, et al. Photonanomedicine: A convergence of photodynamic therapy and nanotechnology[J]. Nanoscale, 2016, 8(25): 12471-12503.
|
[9] |
Li Z, Jiang X, Xiao H, et al. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma[J]. Surg Endosc, 2021, 35(10): 5655-5664.
|
[10] |
Brunaldi VO, Brunaldi JE, Vollet-Filho JD, et al. Photodynamic therapy of extrahepatic cholangiocarcinoma using digital cholangioscopy[J]. Arq Bras Cir Dig, 2020, 33(1): e1490.
|
[11] |
Talreja JP, DeGaetani M, Sauer BG, et al. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment[J]. Photochem Photobiol Sci, 2011, 10(7): 1233-1238.
|
[12] |
Choi HJ, Moon JH, Ko BM, et al. Clinical feasibility of direct peroral cholangioscopy-guided photodynamic therapy for inoperable cholangiocarcinoma performed by using an ultra-slim upper endoscope (with videos)[J]. Gastrointest Endosc, 2011, 73(4): 808-813.
|
[13] |
Zhou J, Xiong L, Liu W, et al. SpyGlass-guided photodynamic therapy for unresectable cholangiocarcinoma: A case report and review of the literature[J]. Front Oncol, 2022, 12: 890735.
|
[14] |
Choi JH, Oh D, Lee JH, et al. Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter[J]. Endoscopy, 2015, 47(11): 1035-1038.
|
[15] |
宋铭杰, 韩青雷, 李佳隆, 等. 内镜下晚期肝外胆管恶性肿瘤消融治疗研究现况[J/CD]. 中华普外科手术学杂志(电子版), 2023, 17(3): 340-342.
|
[16] |
Pereira SP, Jitlal M, Duggan M, et al. PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer[J]. ESMO Open, 2018, 3(5): e000379.
|
[17] |
许博, 席大勇, 蒲唯高, 等. 双金属支架联合光动力治疗及靶向、免疫治疗在远端胆管癌中的应用[J]. 肝胆胰外科杂志, 2021, 33(7): 427-433.
|
[18] |
Moole H, Tathireddy H, Dharmapuri S, et al. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis[J]. World J Gastroenterol, 2017, 23(7): 1278-1288.
|
[19] |
Mohan BP, Chandan S, Khan SR, et al. Photodynamic therapy (PDT), radiofrequency Ablation (RFA) with biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma: A systematic review and meta-analysis[J]. J Clin Gastroenterol, 2022, 56(2): e153-e160.
|
[20] |
Song S, Gong S, Lei T, et al. Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: A Bayesian network meta-analysis[J]. Expert Rev Gastroenterol Hepatol, 2022, 16(6): 555-567.
|
[21] |
Schmidt A, Bloechinger M, Weber A, et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma[J]. United European Gastroenterol J, 2016, 4(4): 570-579.
|
[22] |
Beltrán Hernández I, Yu Y, Ossendorp F, et al. Preclinical and clinical evidence of immune responses triggered in oncologic photodynamic therapy: clinical recommendations[J]. J Clin Med, 2020, 9(2): 333.
|
[23] |
Yu Y, Wang N, Wang Y, et al. Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: A systematic review and meta-analysis[J]. Photodiagnosis Photodyn Ther, 2023, 41: 103318.
|
[24] |
Wentrup R, Winkelmann N, Mitroshkin A, et al. Photodynamic therapy plus chemotherapy compared with photodynamic therapy alone in hilar nonresectable cholangiocarcinoma[J]. Gut Liver, 2016, 10(3): 470-475.
|
[25] |
Gonzalez-Carmona MA, Bolch M, Jansen C, et al. Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma[J]. Aliment Pharmacol Ther, 2019, 49(4): 437-447.
|
[26] |
卢学敏, 刘黎, 许泓, 等. 光化学内化作用及其在基因输送中的应用[J]. 上海交通大学学报(医学版), 2018, 38(3): 353-356.
|
[27] |
Trojan J, Hoffmeister A, Neu B, et al. Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma[J]. Oncologist, 2022, 27(6): e430-e433.
|
[28] |
Wiedmann M, Caca K, Berr F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: A phase Ⅱ pilot study[J]. Cancer, 2003, 97(11): 2783-2790.
|
[29] |
Wagner A, Wiedmann M, Tannapfel A, et al. Neoadjuvant down-sizing of hilar cholangiocarcinoma with photodynamic therapy--long-term outcome of a phase Ⅱ pilot study[J]. Int J Mol Sci, 2015, 16(11): 26619-26628.
|
[30] |
Grendar J, Grendarova P, Sinha R, et al. Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: A systematic review[J]. HPB (Oxford), 2014, 16(4): 297-303.
|
[31] |
Sapisochin G, de Lope CR, Gastaca M, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A Spanish matched cohort multicenter study[J]. Ann Surg, 2014, 259(5): 944-952.
|
[32] |
Vilchez V, Shah MB, Daily MF, et al. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: An analysis of the UNOS database[J]. HPB (Oxford), 2016, 18(1): 29-34.
|
[33] |
Cosgrove ND, Al-Osaimi AM, Sanoff HK, et al. Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation[J]. Am J Transplant, 2014, 14(2): 466-471.
|